Why the study?
Patients with CRT undergoing transvenous lead extraction may carry higher risk due to increased comorbidities, but whether they have more comorbidities and higher 30-day mortality than non-CRT patients was unknown.
Does transvenous lead extraction in patients with CRT devices increase 30-day mortality compared to non-CRT devices in patients undergoing lead extraction?
Does transvenous lead extraction in patients with CRT devices increase 30-day mortality compared to non-CRT devices in patients undergoing lead extraction?
Transvenous lead extraction in CRT patients is not associated with increased 30-day mortality compared to non-CRT patients, despite a higher burden of comorbidities.
No takes yet. Share an insight, caveat, or question.
CRT patients show similar TLE 30-day mortality despite more comorbidities; leaves open independent device effects in prospective studies.
Gould et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: